Fidia Pharma

Fidia Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on Hyaluronic Acid (HA) in eye care, health&wellness care, joint care, skin care, specialty care. Over 60 years of R&D have placed Fidia at the forefront in the production of natural and functionalized HA, with different ranges of molecular weight (~1,200 patents). Fidia extends its global reach through local partners in +120 countries worldwide, as well as wholly owned subsidiaries in USA, Germany, Austria, Spain, France, Russia, Czech Republic, Slovakia, Romania, Poland, Egypt, the Middle East and Turkey. Fidia has more than 1,700 global employees and boasts a turnover exceeding €510 million (2024), nearly 50 percent of which is generated abroad. At Fidia Pharma, we are committed to fostering a professional, informative, and respectful community. Our Social Media Netiquette ensures that discussions remain ethical, compliant, and valuable for everyone. Take a look at our Netiquette here: https://www.fidiapharma.com/social-media-netiquette/ If you come across any content that breaches these rules, please report it to us directly: https://www.fidiapharma.com/our-group/contacts/

Company Details

Employees
1.57K
Address
Via Ponte Della Fabbrica 3/a, Abano Terme,pd 35031,italy
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Abano Terme, PD
Looking for a particular Fidia Pharma employee's phone or email?

Fidia Pharma Questions

News

Fidia Farmaceutici Continues On Its Growth Path: Fidia Signed A Binding Agreement With Sanofi For The Acquisition Of A Portfolio Of Anti-inflammatory Drugs - PR Newswire

Fidia Farmaceutici Continues On Its Growth Path: Fidia Signed A Binding Agreement With Sanofi For The Acquisition Of A Portfolio Of Anti-inflammatory Drugs PR Newswire

FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment - Mesothelioma Center

FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment Mesothelioma Center

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant